Patent details

EP2849754 Title: LINAGLIPTIN, A XANTHINE DERIVATIVE AS DPP-4 INHIBITOR, FOR USE IN THE TREATMENT OF SIRS AND/OR SEPSIS

Basic Information

Publication number:
EP2849754
PCT Application Number:
EP2013059828
Type:
European Patent Granted for LU
Legal Status:
Revoked
Application number:
EP137224184
PCT Publication Number:
WO2013171166
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
LINAGLIPTIN, A XANTHINE DERIVATIVE AS DPP-4 INHIBITOR, FOR USE IN THE TREATMENT OF SIRS AND/OR SEPSIS
French Title of Invention:
LINAGLIPTINE, UN DÉRIVÉ DE XANTHINE EN TANT QU'INHIBITEUR DE DPP-4, POUR L'UTILISATION DANS LE TRAITEMENT DE SIRS ET/OU D'UNE SEPSIE
German Title of Invention:
LINAGLIPTIN, EIN XANTHINDERIVAT ALS DPP-4-HEMMER, ZUR VERWENDUNG BEI DER BEHANDLUNG VON SIRS UND/ODER SEPSIS
SPC Number:

Dates

Filing date:
13/05/2013
Grant date:
14/09/2022
EP Publication Date:
25/03/2015
PCT Publication Date:
21/11/2013
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
14/09/2022
EP B1 Publication Date:
14/09/2022
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
13/05/2023
Expiration date:
13/05/2033
Renunciation date:
Revocation date:
27/05/2025
Annulment date:

Owner

From:
07/09/2022
 
 

Name:
Boehringer Ingelheim International GmbH
Address:
Binger Strasse 173, 55216 Ingelheim am Rhein, Germany (DE)

Inventor

1

Name:
KLEIN, Thomas
Address:
Germany (DE)

2

Name:
DAIBER, Andreas
Address:
Germany (DE)

3

Name:
MUENZEL, Thomas
Address:
Germany (DE)

4

Name:
DUGI, Klaus
Address:
Germany (DE)

5

Name:
MARK, Michael
Address:
Germany (DE)

Priority

Priority Number:
12167893
Priority Date:
14/05/2012
Priority Country:
European Patent Office (EPO) (EP)

Classification

IPC classification:
A61K 31/522; A61P 29/00;

Publication

European Patent Bulletin

1

Issue number:
202237
Publication date:
14/09/2022
Description:
Grant (B1)

2

Issue number:
202527
Publication date:
02/07/2025
Description:
Revocation of the European patent

3

Issue number:
202241
Publication date:
12/10/2022
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages